Exclusive interviews with leading policymakers that convey the true policy message that impacts markets.
Reporting on key macro data at the time of release.
- Emerging MarketsEmerging Markets
Real-time insight of emerging markets in CEMEA, Asia and LatAm region
- MNI ResearchMNI Research
Actionable insight on monetary policy, balance sheet and inflation with focus on global issuance. Analysis on key political risk impacting the global markets.
- About Us
China reported its first patent of a vaccine against the Covid-19 virus which can be mass-produced, the Beijing Youth Daily reported on Monday. Named Ad5-nCoV, the vaccine was developed by a research team led by Chen Wei at the Military Science Academy in conjunction with CanSino Biologics. The vaccine has proved its efficacy in previous trials and is entering phase III clinical trails, reported the Daily.